Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBITDA: 2016-2025

Historic EBITDA for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to -$2.2 million.

  • cbdMD's EBITDA fell 116.65% to -$685,816 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 34.77%. This contributed to the annual value of -$2.2 million for FY2025, which is 34.77% up from last year.
  • cbdMD's EBITDA amounted to -$2.2 million in FY2025, which was up 34.77% from -$3.3 million recorded in FY2024.
  • cbdMD's 5-year EBITDA high stood at -$2.2 million for FY2025, and its period low was -$78.3 million during FY2022.
  • Its 3-year average for EBITDA is -$9.3 million, with a median of -$3.3 million in 2024.
  • In the last 5 years, cbdMD's EBITDA tumbled by 298.99% in 2022 and then surged by 85.26% in 2024.
  • Yearly analysis of 5 years shows cbdMD's EBITDA stood at -$19.6 million in 2021, then tumbled by 298.99% to -$78.3 million in 2022, then skyrocketed by 71.27% to -$22.5 million in 2023, then soared by 85.26% to -$3.3 million in 2024, then spiked by 34.77% to -$2.2 million in 2025.